An interventional study of TAC intervention in Alcohol Addiction, sponsored by Versailles Hospital. Not yet recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-16.
Sponsored by Versailles Hospital · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 94 studies in Alcoholism with a site in France — 24 open to participants now, 25 under way, 1 of them phase 3. Alcoholism · France.
Among the 94 studies in Alcoholism with a site in France, this one is the 40th largest by planned enrollment of the 58 interventional ones that give a count, is one of 8 that started in 2026, is one of 42 with no phase, reaches primary completion later than 11 of the 24 other live ones, and was the 89th registered.
1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.
Browse Alcoholism studies →24 of the 94 studies in Alcoholism with a site in France are open now. Recruiting first, the newest first:
Institut National de la Santé Et de la Recherche Médicale, France · Sites in France
Ages 18–65
Hospices Civils de Lyon · Sites in France
Ages 18+
Centre Hospitalier Universitaire de Nīmes · Sites in France
Ages 18+
CHU de Reims · Sites in France
Ages 18–65 · Healthy volunteers
Centre Hospitalier Régional d'Orléans · Sites in France
Ages 18+ · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
94 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 6 · Phase 3 8 · Phase 4 2
First in 2002; this study’s year is marked. 8 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 98 is above the median of 88 across 1,433 interventional studies indexed under Alcoholism.
Median enrollment 153 across the 58 interventional studies, 113 across the 36 observational. Of the 59 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 94 have an industry lead sponsor. The 10 most frequent:
Versailles Hospital is the lead sponsor of 74 studies on the registry; 16 are open to participants now.
Versailles Hospital has 1 study filed under Alcoholism — fewer than ten, so there is no comparison to draw.
5 of the studies in Alcoholism with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07369245Versailles HospitalTechniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction | 2027-07-15 |
| NCT04773691Centre Hospitalier Universitaire DijonEffectiveness of High-frequency rTMS in Reducing Alcohol Consumption in Non-abstinent Patients With an Alcohol Use Disorder | 2027-08 |
| NCT06706349Centre Hospitalier Universitaire de BesanconEffect of Adapted Physical Activity on Sleep Quality in People With Alcohol Use Disorder | 2027-10 |
| NCT06675539Etablissement Public de Santé Barthélemy DurandValidation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS) | 2027-10 |
| NCT07844720Institut National de la Santé Et de la Recherche Médicale, FranceStudy on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder | 2027-10-22 |
Add all 5 to your calendar (.ics) → With an account.
Among the 94 studies in Alcoholism with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Many patients are considering the use of so-called "hypnosis" treatments in the field of addictions. However, these techniques lack sufficient levels of evidence with regard to the standards required by Evidence-Based Medicine.
In other domains, however, hypnosis has demonstrated an interesting level of evidence, particularly in pain management.
The investigators will focus on the "Techniques for Activating Consciousness" (TAC), which represent an optimized therapeutic approach derived from hypnotic therapy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Decompensated psychiatric pathology contraindicating therapy:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: TAC intervention
Patients receiving TAC (Techniques for Activating Consciousness) intervention in addition to standard care
The patient's ability to control alcohol consumption during outpatient follow-up in a CSAPA
The main outcome measure will be the number of weeks to achieve the targeted goal between T0 (first consultation when the objective is set) and M6 (cumulative time).
Time frame: 6 months
Controlling addictive behavior in both groups
Evaluation criteria for both groups: * Cumulative time over 12 months during which the subject meets the target of controlling addictive behavior; percentage of time at target between T0-M6 and T0-M12; number of weeks to reach the target; number of relapses between T0-M6 and T0-M12; time between achieving the target and relapse between T0-M12 * Craving intensity (weekly via electronic patient questionnaire) * Levels of anxiety and depression (HAD scale) and global relaxation (IERS-3), at T0, M6, and M12 * Care received (interventions, medications) from medical records at M6 and M12 * Patient opinion questionnaire at M6 and M12 on what was perceived as useful or not in their treatment
Time frame: 12 months
Evaluation criteria for the TAC group
Weekly self-reports (via electronic patient questionnaire) on the frequency of exercise practice, perceived effectiveness of TAC (Techniques for Activating Consciousness) on their addictive issues (VAS 0-10), and tolerance of TAC (Techniques for Activating Consciousness)
Time frame: 12 months
Start is estimated for Apr 2026; primary completion for Jul 2027, 15 months later.
Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 15 months is below that.
Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Versailles Hospital